| __timestamp | Dr. Reddy's Laboratories Limited | Intra-Cellular Therapies, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 12402000000 | 21226345 |
| Thursday, January 1, 2015 | 17449000000 | 87718074 |
| Friday, January 1, 2016 | 17834000000 | 93831530 |
| Sunday, January 1, 2017 | 19551000000 | 79419009 |
| Monday, January 1, 2018 | 18265000000 | 132166913 |
| Tuesday, January 1, 2019 | 15607000000 | 89124838 |
| Wednesday, January 1, 2020 | 15410000000 | 65782137 |
| Friday, January 1, 2021 | 16541000000 | 88845513 |
| Saturday, January 1, 2022 | 17482000000 | 134715000 |
| Sunday, January 1, 2023 | 19381000000 | 180142000 |
| Monday, January 1, 2024 | 22873000000 |
Infusing magic into the data realm
In the ever-evolving pharmaceutical industry, research and development (R&D) spending is a key indicator of a company's commitment to innovation. This analysis compares the R&D expenditures of Intra-Cellular Therapies, Inc. and Dr. Reddy's Laboratories Limited from 2014 to 2023.
Dr. Reddy's Laboratories consistently allocated a significant portion of its resources to R&D, with expenditures growing by approximately 84% over the decade. In contrast, Intra-Cellular Therapies, Inc. demonstrated a more modest increase, with R&D spending rising by around 750% during the same period, albeit from a much smaller base.
The data reveals a clear trend: while Dr. Reddy's Laboratories maintains a steady investment in innovation, Intra-Cellular Therapies, Inc. is rapidly scaling its efforts, reflecting its aggressive pursuit of new therapeutic solutions. Missing data for 2024 suggests ongoing developments in the industry.
Analyzing R&D Budgets: Novo Nordisk A/S vs Dr. Reddy's Laboratories Limited
Sanofi or Intra-Cellular Therapies, Inc.: Who Invests More in Innovation?
R&D Insights: How Genmab A/S and Dr. Reddy's Laboratories Limited Allocate Funds
Research and Development Investment: Incyte Corporation vs Intra-Cellular Therapies, Inc.
R&D Insights: How Intra-Cellular Therapies, Inc. and Alpine Immune Sciences, Inc. Allocate Funds
Who Prioritizes Innovation? R&D Spending Compared for Intra-Cellular Therapies, Inc. and CymaBay Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Dr. Reddy's Laboratories Limited and Madrigal Pharmaceuticals, Inc.
Dr. Reddy's Laboratories Limited or Grifols, S.A.: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for Dr. Reddy's Laboratories Limited and Viking Therapeutics, Inc.
Comparing Innovation Spending: Dr. Reddy's Laboratories Limited and Rhythm Pharmaceuticals, Inc.
Research and Development Investment: Dr. Reddy's Laboratories Limited vs Mesoblast Limited
Analyzing R&D Budgets: Dr. Reddy's Laboratories Limited vs Evotec SE